A new drug Odomzo (sonidegib) has received US Food and Drug Administration’s approval for treatment of locally advanced basal cell carcinoma that has recurred either following a surgery or radiation therapy, or…
Tag: FDA
Cholesterol drug Praluent lands US FDA approval
The US Food and Drug Administration (FDA) has stamped its seal of approval on the first cholesterol-lowering treatment approved in a new class of drugs known as proprotein convertase subtilisin kexin type…
US FDA approves cystic fibrosis drug
In a landmark development, the first cystic fibrosis drug – Orkambi (lumacaftor 200 mg/ivacaftor 125 mg) – capable of treating the cause of the disease in people who have two copies of…
Orexigen ends study of obesity drug Contrave
Orexigen Therapeutics along with its partner Takeda announced termination of the Light Study a cardiovascular (CV) outcomes trial of their obesity drug Contrave (naltrexone HCI and bupropion HCl extended-release tablets) after a…
Breo Ellipta lands FDA approval for asthma treatment in US
GlaxoSmithKline plc and Theravance, Inc have announced that their drug Breo Ellipta (fluticasone furoate/vilanterol [FF/VI]) has been approved by the US Food and Drug Administration (FDA) as a once-daily treatment of asthma…